Valuation: STCube, Inc.

Market Cap 504B 335M 293M 271M 250M 474M 31.99B 483M 3.25B 1.26B 15.69B 1.26B 1.23B 54.56B P/E 2024
-19.4x
P/E 2025 -25.6x
Enterprise Value 447B 297M 260M 240M 222M 420M 28.34B 428M 2.88B 1.12B 13.9B 1.11B 1.09B 48.34B EV / Sales 2024
44.3x
EV / Sales 2025 71.5x
Free-Float
92.57%
Yield 2024 *
-
Yield 2025 -
24/10/24 STCube, Inc. announced that it has received KRW 13.00000464 billion in funding CI
26/08/24 STCube, Inc. announced that it expects to receive KRW 13.00000464 billion in funding CI
28/03/24 STCube, Inc.(KOSDAQ:A052020) dropped from S&P Global BMI Index CI
06/09/23 Global markets live: Apple, Alphabet, Roku, Amazon, General Mills... Zonebourse
21/03/23 STCube, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
08/03/22 STCube to Raise $36 Million via Stock Sale; Shares Surge 10% MT
28/12/20 STCube, Inc. announced that it has received KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
18/12/20 STCube, Inc. announced that it expects to receive KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
12/07/20 Samsung Biologics Signs Additional Development and Manufacturing Agreement with STCube CI
02/03/20 Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug CI
25/05/18 STCube, Inc. announced that it has received KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm CI
25/04/18 STCube, Inc. announced that it expects to receive KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm and other investors CI
19/09/16 STCube, Inc.(KOSDAQ:A052020) added to S&P Global BMI Index CI
1 day-6.31%
1 week-14.12%
Current month-14.12%
1 month-28.52%
3 months-51.18%
6 months-11.67%
Current year-9.51%
1 week 7,400
Extreme 7400
8,720
1 month 7,400
Extreme 7400
11,750
Current year 6,950
Extreme 6950
22,500
1 year 6,810
Extreme 6810
22,500
3 years 3,940
Extreme 3940
22,500
5 years 3,940
Extreme 3940
28,500
10 years 3,940
Extreme 3940
28,600
Manager TitleAgeSince
Chief Executive Officer 61 29/03/2013
Director of Finance/CFO 54 -
Chief Tech/Sci/R&D Officer 62 01/03/2014
Director TitleAgeSince
Director/Board Member 61 01/03/2013
Director/Board Member 54 01/03/2013
Director/Board Member 62 01/03/2014
Date Insider Type Main position Quantity % Market Cap.
03/12/24Buy

Chief Technology Officer

164,014 0.2515%
03/12/24Buy

Chief Financial Officer

47,582 0.0730%
03/12/24
Bio Medical Holdings Corp.
BuyCompany 449,447 0.6892%
Change 5-day change 1-year change 3-year change Capi.($)
-6.31%-14.12%+8.80%-49.18% 355M
-4.45%-7.85%+31.51%+13.23% 117B
-3.52%-16.11%+380.86%+869.73% 53.9B
+1.41%-17.71%+159.17%+384.10% 48.19B
-1.76%-7.62%+107.94%+204.81% 39.36B
-2.35%+2.58%+122.00%+92.67% 30.22B
-0.34%-4.11%+24.06%+55.99% 29.73B
-4.10%-1.40%-17.47%-36.70% 22.87B
-4.13%-9.10%+11.19%+66.09% 18.85B
-5.46%-13.15%+69.21%+127.84% 17.93B
Average -3.10%-5.65%+89.73%+172.86% 37.85B
Weighted average by Cap. -2.81%-5.30%+109.89%+217.02%

Financials

2024 2025
Net sales 11.3B 7.5M 6.58M 6.07M 5.6M 10.63M 717M 10.82M 72.76M 28.31M 352M 28.18M 27.55M 1.22B 6.98B 4.64M 4.06M 3.75M 3.46M 6.57M 443M 6.69M 44.98M 17.5M 217M 17.42M 17.03M 756M
Net income -21.44B -14.23M -12.48M -11.51M -10.63M -20.17M -1.36B -20.54M -138M -53.72M -667M -53.46M -52.28M -2.32B -21.8B -14.47M -12.69M -11.71M -10.81M -20.51M -1.38B -20.88M -140M -54.63M -678M -54.37M -53.17M -2.36B
Net Debt -79.55B -52.82M -46.3M -42.72M -39.46M -74.86M -5.05B -76.21M -512M -199M -2.48B -198M -194M -8.61B -57.42B -38.13M -33.42M -30.83M -28.48M -54.03M -3.64B -55.01M -370M -144M -1.79B -143M -140M -6.21B
Logo STCube, Inc.
STCube Inc is a Korea-based company mainly engaged in the distribution of lens modules and related components. The Company operates its business through two segments. The Distribution segment is engaged in the industrial lens modules and related parts distribution, basic skin care products distribution and Cynthia basic skin care products manufacture and distribution business. The Biotechnology segment is engaged in the research, development and licensing of immunomodulatory anticancer drug therapeutic candidates.
Employees
13
Date Price Change Volume
08/07/26 ₩7,420.00 -6.31% 244,834
07/07/26 ₩7,920.00 -2.10% 201,443
06/07/26 ₩8,090.00 -0.12% 206,421
03/07/26 ₩8,100.00 -2.17% 234,216
02/07/26 ₩8,280.00 -5.37% 336,347
  1. Stock Market
  2. Stocks
  3. A052020 Stock